ERYTECH’s IPO a remarkable success, raising €17.7 million Post author:admERY Post published:April 30, 2013 Post category:Newsroom ERYTECH today announced the success of its IPO in compartment C of the NYSE Euronext regulated market in Paris, raising more than the target amount of €15 million. You Might Also Like Erytech announces trading resumption of its ordinary shares on Euronext Paris November 10, 2017 ERYTECH Presents New Preclinical Anti-Tumor Data on erymethionase at AACR 2017 March 20, 2017 ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC June 26, 2019
ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC June 26, 2019